VitaNova Life Sciences (VNOV) Other Accumulated Expenses (2019 - 2025)

VitaNova Life Sciences (VNOV) reported Other Accumulated Expenses of $3951.0 for Q4 2025, up 338.03% on a YoY basis from $902.0 in Q4 2024, and up 222.27% quarter-over-quarter from $1226.0 in Q3 2025.

VitaNova Life Sciences (VNOV) Other Accumulated Expenses (2019 - 2025) Analysis & Trends

VitaNova Life Sciences has reported Other Accumulated Expenses for 5 years, with the latest figure at $3951.0 in Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses rose 338.03% year-over-year to $3951.0; the trailing twelve-month figure through Oct 2025 stood at $3951.0 (up 338.03% YoY), and the FY2025 full-year result was $820.0, down 90.12% from the prior year.
  • Other Accumulated Expenses for Q4 2025 stood at $3951.0, up from $1226.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $28563.0 in Q2 2021, with the low at $820.0 in Q2 2025.
  • Historically, Other Accumulated Expenses has averaged $5713.1 across 3 years, with a median of $2795.0 in 2025.
  • The largest YoY upside for Other Accumulated Expenses was 338.03% in 2025 against a maximum downside of 90.12% in 2025.
  • VitaNova Life Sciences' Other Accumulated Expenses stood at $28563.0 in 2021, then sank by 96.84% to $902.0 in 2024, then soared by 338.03% to $3951.0 in 2025.
  • The last three Other Accumulated Expenses figures came in at $3951.0 (Q4 2025), $1226.0 (Q3 2025), and $820.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn -
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn
8 111 107.47 Mn 25.61 Mn 23.58 Mn
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn
10 VitaNova Life Sciences - - 316,343.00

Historic Data

Download Data
DateValue
Oct 31, 2025 3,951.00
Jul 31, 2025 1,226.00
Apr 30, 2025 820.00
Jan 31, 2025 2,795.00
Oct 31, 2024 902.00
Jul 31, 2024 1,859.00
Apr 30, 2024 8,302.00
Apr 30, 2021 28,563.00
Jan 31, 2021 3,000.00
Oct 31, 2020 11,816.00
Jul 31, 2020 30,002.00
Apr 30, 2020 18,755.00
Jan 31, 2020 7,215.00
Oct 31, 2019 7,836.00